Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

Objectives To develop evidence-based points to consider for cost-effective use of biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in the treatment of inflammatory rheumatic diseases, specifically rheumatoid arthritis, psoriatic arthritis and axial spondyloarthrit...

Full description

Bibliographic Details
Main Authors: Daniel Aletaha, Katerina Chatzidionysiou, Alfons A den Broeder, Paco M J Welsing, Rieke Alten, Bart van den Bemt, Denis Mulleman, James Galloway, John Isaac, P Verschueren, Arnold G Vulto, Céleste J T van der Togt, Lise Verhoef
Format: Article
Language:English
Published: BMJ Publishing Group 2023-03-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/1/e002898.full

Internet

https://rmdopen.bmj.com/content/9/1/e002898.full

Similar Items